Health professionals are worried that potential donors would be
put off by such restrictions and questions regarding their sexual history. Furthermore,
they question how a health professional would go about questioning family and friends
about the sexual history of a deceased donor?

However, the CDC says that rather than turn away donors who have
had more than two sexual partners in a year, they would merely carry out more tests
than they usually would.

We are not convinced by this new proposal and it does not take
into account how this information is to be gathered and even if someone is categorised
as “promiscuous”, they might have been having safe sex, as most responsible people
do. If you are responsible enough to sign up as a donor, you are probably responsible
enough to have been careful about your own sexual health. As for carrying out additional
screening of organs for transplant, rigorous screening already takes place.

Source:
http://www.theonlineclinic.co.uk/news/SyndicationService.asmx/GetRssCategory?categoryName=Sexual%20Health

Although both vaccines are 70% effective in preventing the strains
of HPV that cause cervical cancer, Gardasil is effective at preventing 2 other strains
of the HPV virus which are the cause of 90% of genital warts cases.

The decision to use Gardasil is based on figures released by the
Health Protection Agency, which includes information that 75,000 new cases of genital
warts were reported in 2010 and which costs the NHS £17 million each year to treat.

Considering the association between the HPV virus and mouth cancer,
The British Dental Health Association has asked that the vaccination programme be
extended to boys also. The vaccination would also prevent throat, penile and anal
cancers.

If you have genital warts then The Online Clinic can prescribe
treatments to eradicate the warts. The most popular treatment is Warticon,
which will normally eliminate the warts within a few weeks.

Source:
http://www.theonlineclinic.co.uk/news/SyndicationService.asmx/GetRssCategory?categoryName=Sexual%20Health

In the UK, one in twenty gay men is infected with the virus and
that number is even higher in London where one in eleven men are believed to be HIV
positive.  Over half of the men and women
who tested positive well into their condition last year were past the stage that health
professionals would consider the optimum for treatment to commence.

The Health Protection Agency therefore wishes to promote the idea
of universal testing in GP practices for new patients and where patients are admitted
to hospital in areas around Britain that are deemed at high risk.

Looking at these statistics, this seems like a worthy request
and especially when we hear that only 4% of England’s population were tested for the
virus in 2010. A spokesperson for the National Aids Trust rightly suggested that people
are scared of being tested but instead should be fearful about living with undiagnosed
HIV. With only 4% of English people having taken a test in 2010 and one fifth declining
the offer, it is high time British people woke up to the problem instead of watching
infection rates increase and presuming that they themselves are impervious to the
virus.

Source:
http://www.theonlineclinic.co.uk/news/SyndicationService.asmx/GetRssCategory?categoryName=Sexual%20Health

10% of the group believed that wearing 2 condoms during sex would
reduce their risk of catching a sexually transmitted disease. Furthermore, at the
survey’s outset, 92% of the group said that they felt confident about their knowledge
of sexual health and contraception.

Last year, the Health Protection Agency noted 12,000 more cases
of sexually transmitted infections reported compared with the year before and also
highlighted that the 15 to 24 year olds represented the most at risk age bracket.

Of course this ignorance is not specific to Cambridge students
but to all young people. Really, the main observation is the 92% who felt confident
about what they knew. If they are not aware of what they do not know, how can they
be expected to learn? The information simply is either not accessible or is not taught
in schools.

Source:
http://www.theonlineclinic.co.uk/news/SyndicationService.asmx/GetRssCategory?categoryName=Sexual%20Health

The gel form of the drug stops the spread of the herpes virus
by disabling its DNA enzyme and reduces the risk of contracting herpes simplex infections
as well as HIV infections. It has always been known to inhibit the reproduction of
the HIV virus but this study highlights its potential regarding HSV. HSV in its shedding
phase is contractible even when infected partners present as asymptomatic.

HIV and herpes are closely associated and those who have the herpes
virus and who are exposed to the herpes virus are more likely to contract HIV than
those who do not carry the herpes virus.

Tenofovir is converted by human tissue into a form that inhibits
the activity of the HIV virus and now we know that it does the same for herpes
simplex. The study examined HSV infected group cells and individual cells and
it was proven that the drug in high concentrations stopped the reproduction of the
virus. Furthermore, mice treated with tenofovir and which were infected with herpes
experienced no symptoms of herpes and lived longer.

Taking the drug orally will not affect the HSV virus but there
is approximately 100 times the amount of the drug present in the gel form when administered
directly to the vaginal tissues. Safety and efficacy studies will need to be carried
out before the drug is sold in this form and for this use but this could be a breakthrough
preventative treatment for a virus that stays with an infected individual for life.

Source:
http://www.theonlineclinic.co.uk/news/SyndicationService.asmx/GetRssCategory?categoryName=Sexual%20Health